AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

DIAGNOSTICS INTELLIGENCE: Abbott to distribute Vysis' genomic tests for breast and bladder cancer.

Chemical Business Newsbase

| May 24, 2001 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Vysis Inc of Downers Grove, IL has given Abbott Laboratories of Abbott Park, IL, distribution rights to its 2 genomic tests for breast and bladder cancer.

Abbott will be the exclusive distributor in North America and Europe of the DNA-based tests PathVysion HER-2 assay and the UroVysion assay.

PathVysion HER-2 assay detects and quantify the HER-2 gene in breast cancer patients, while UroVysion assay is for the detection of genetic changes in the urine's bladder cancer cells.

Both tests …

Related articles from newspapers, magazines, journals, and more
ABBOTT LABORATORIES, ARTUS LAUNCH NEW DIAGNOSTIC TESTS.
News wire article from: Asia Africa Intelligence Wire October 29, 2003 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily